Literature DB >> 24060865

History of myeloid-derived suppressor cells.

James E Talmadge1, Dmitry I Gabrilovich.   

Abstract

Tumour-induced granulocytic hyperplasia is associated with tumour vasculogenesis and escape from immunity via T cell suppression. Initially, these myeloid cells were identified as granulocytes or monocytes; however, recent studies have revealed that this hyperplasia is associated with populations of multipotent progenitor cells that have been identified as myeloid-derived suppressor cells (MDSCs). The study of MDSCs has provided a wealth of information regarding tumour pathobiology, has extended our understanding of neoplastic progression and has modified our approaches to immune adjuvant therapy. In this Timeline article, we discuss the history of MDSCs, their influence on tumour progression and metastasis, and the crosstalk between tumour cells, MDSCs and the host macroenvironment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24060865      PMCID: PMC4358792          DOI: 10.1038/nrc3581

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  191 in total

1.  Mechanisms underlying hematopoietic stem cell mobilization induced by the CXC chemokine interleukin-8.

Authors:  J F Pruijt; R Willemze; W E Fibbe
Journal:  Curr Opin Hematol       Date:  1999-05       Impact factor: 3.284

2.  Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation.

Authors:  V Bronte; D B Chappell; E Apolloni; A Cabrelle; M Wang; P Hwu; N P Restifo
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

3.  A STUDY OF THE LEUKEMOID RESPONSE TO TRANSPLANTABLE A-280 TUMOR IN MICE.

Authors:  E J LAPPAT; M CAWEIN
Journal:  Cancer Res       Date:  1964-02       Impact factor: 12.701

4.  Fas-FasL-mediated CD4+ T-cell apoptosis following stem cell transplantation.

Authors:  R K Singh; M L Varney; S Buyukberber; K Ino; A G Ageitos; E Reed; S Tarantolo; J E Talmadge
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

5.  Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas.

Authors:  A Nishie; M Ono; T Shono; J Fukushi; M Otsubo; H Onoue; Y Ito; T Inamura; K Ikezaki; M Fukui; T Iwaki; M Kuwano
Journal:  Clin Cancer Res       Date:  1999-05       Impact factor: 12.531

6.  Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells.

Authors:  Ibrahim Younos; Moses Donkor; Traci Hoke; Alicia Dafferner; Holly Samson; Sherry Westphal; James Talmadge
Journal:  Int Immunopharmacol       Date:  2011-03-02       Impact factor: 4.932

7.  MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.

Authors:  James Finke; Jennifer Ko; Brian Rini; Pat Rayman; Joanna Ireland; Peter Cohen
Journal:  Int Immunopharmacol       Date:  2011-02-11       Impact factor: 4.932

8.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells.

Authors:  T Asahara; T Takahashi; H Masuda; C Kalka; D Chen; H Iwaguro; Y Inai; M Silver; J M Isner
Journal:  EMBO J       Date:  1999-07-15       Impact factor: 11.598

9.  G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models.

Authors:  Farbod Shojaei; Xiumin Wu; Xueping Qu; Marcin Kowanetz; Lanlan Yu; Martha Tan; Y Gloria Meng; Napoleone Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-03       Impact factor: 11.205

10.  Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells.

Authors:  Emmanouil Chavakis; Alexandra Aicher; Christopher Heeschen; Ken-ichiro Sasaki; Ralf Kaiser; Naual El Makhfi; Carmen Urbich; Thorsten Peters; Karin Scharffetter-Kochanek; Andreas M Zeiher; Triantafyllos Chavakis; Stefanie Dimmeler
Journal:  J Exp Med       Date:  2004-12-28       Impact factor: 14.307

View more
  480 in total

1.  Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency.

Authors:  Bahey Salem; Samantha Miner; Nancy F Hensel; Minoo Battiwalla; Keyvan Keyvanfar; David F Stroncek; Adrian P Gee; Patrick J Hanley; Catherine M Bollard; Sawa Ito; A John Barrett
Journal:  Cytotherapy       Date:  2015-09-28       Impact factor: 5.414

2.  Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.

Authors:  James N Kochenderfer; Mark E Dudley; Sadik H Kassim; Robert P T Somerville; Robert O Carpenter; Maryalice Stetler-Stevenson; James C Yang; Giao Q Phan; Marybeth S Hughes; Richard M Sherry; Mark Raffeld; Steven Feldman; Lily Lu; Yong F Li; Lien T Ngo; Andre Goy; Tatyana Feldman; David E Spaner; Michael L Wang; Clara C Chen; Sarah M Kranick; Avindra Nath; Debbie-Ann N Nathan; Kathleen E Morton; Mary Ann Toomey; Steven A Rosenberg
Journal:  J Clin Oncol       Date:  2014-08-25       Impact factor: 44.544

Review 3.  Biomarkers for glioma immunotherapy: the next generation.

Authors:  Jennifer S Sims; Timothy H Ung; Justin A Neira; Peter Canoll; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2015-02-28       Impact factor: 4.130

4.  Endoplasmic reticulum stress induced LOX-1 CD15+ polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma.

Authors:  Jiang Nan; Yan-Fang Xing; Bo Hu; Jian-Xin Tang; Hui-Min Dong; Yu-Mei He; Dan-Yun Ruan; Qing-Jian Ye; Jia-Rong Cai; Xiao-Kun Ma; Jie Chen; Xiu-Rong Cai; Ze-Xiao Lin; Xiang-Yuan Wu; Xing Li
Journal:  Immunology       Date:  2017-12-21       Impact factor: 7.397

Review 5.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

6.  Defective TGF-β signaling in bone marrow-derived cells prevents hedgehog-induced skin tumors.

Authors:  Qipeng Fan; Dongsheng Gu; Hailan Liu; Ling Yang; Xiaoli Zhang; Mervin C Yoder; Mark H Kaplan; Jingwu Xie
Journal:  Cancer Res       Date:  2013-11-26       Impact factor: 12.701

7.  Melanoma induced immunosuppression is mediated by hematopoietic dysregulation.

Authors:  Neha Kamran; Youping Li; Maria Sierra; Mahmoud S Alghamri; Padma Kadiyala; Henry D Appelman; Marta Edwards; Pedro R Lowenstein; Maria G Castro
Journal:  Oncoimmunology       Date:  2017-12-14       Impact factor: 8.110

8.  Myeloid-derived suppressor cells in the development of lung cancer.

Authors:  Myrna L Ortiz; Lily Lu; Indu Ramachandran; Dmitry I Gabrilovich
Journal:  Cancer Immunol Res       Date:  2013-10-18       Impact factor: 11.151

9.  IL-12 promotes myeloid-derived suppressor cell recruitment and bacterial persistence during Staphylococcus aureus orthopedic implant infection.

Authors:  Cortney E Heim; Debbie Vidlak; Tyler D Scherr; Curtis W Hartman; Kevin L Garvin; Tammy Kielian
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

Review 10.  Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.

Authors:  Audry Fernández; Liliana Oliver; Rydell Alvarez; Luis E Fernández; Kelvin P Lee; Circe Mesa
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.